126 related articles for article (PubMed ID: 26189527)
1. A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
Kobayashi M; Furuta K; Kitamura H; Oguchi K; Arai M; Koike S; Nakazawa K
Clin J Gastroenterol; 2011 Aug; 4(4):236-241. PubMed ID: 26189527
[TBL] [Abstract][Full Text] [Related]
2. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population.
Wang Y; Yang Q; Li S; Luo R; Mao S; Shen J
Clin Radiol; 2019 May; 74(5):407.e1-407.e10. PubMed ID: 30799097
[TBL] [Abstract][Full Text] [Related]
3. Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma.
Ide R; Oshita A; Nishisaka T; Nakahara H; Aimitsu S; Itamoto T
World J Hepatol; 2017 Dec; 9(36):1378-1384. PubMed ID: 29359023
[TBL] [Abstract][Full Text] [Related]
4. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma.
Park SE; Lee SH; Yang JD; Hwang HP; Hwang SE; Yu HC; Moon WS; Cho BH
Korean J Hepatobiliary Pancreat Surg; 2013 Nov; 17(4):152-6. PubMed ID: 26155231
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.
Coulouarn C; Cavard C; Rubbia-Brandt L; Audebourg A; Dumont F; Jacques S; Just PA; Clément B; Gilgenkrantz H; Perret C; Terris B
Carcinogenesis; 2012 Sep; 33(9):1791-6. PubMed ID: 22696594
[TBL] [Abstract][Full Text] [Related]
10. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study.
Kim J; Joo DJ; Hwang S; Lee JM; Ryu JH; Nah YW; Kim DS; Kim DJ; You YK; Yu HC
World J Gastrointest Surg; 2023 Jul; 15(7):1340-1353. PubMed ID: 37555110
[TBL] [Abstract][Full Text] [Related]
12. The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma.
Lu L; Zhang C; Yu X; Zhang L; Feng Y; Wu Y; Xia J; Chen X; Zhang R; Zhang J; Jia N; Zhang S
J Oncol; 2022; 2022():4691172. PubMed ID: 36157231
[TBL] [Abstract][Full Text] [Related]
13. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
14. Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report.
Nugroho A; Lee KW; Lee KB; Kim HS; Kim H; Yi NJ; Suh KS
Ann Hepatobiliary Pancreat Surg; 2018 Aug; 22(3):287-291. PubMed ID: 30215052
[TBL] [Abstract][Full Text] [Related]
15. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
16. Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC).
Bahra M; Yahyazadeh A
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765731
[TBL] [Abstract][Full Text] [Related]
17. Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma.
Kim M; Hwang S; Song GW; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
Korean J Transplant; 2021 Jun; 35(2):116-123. PubMed ID: 35769525
[TBL] [Abstract][Full Text] [Related]
18. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
19. Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma.
Ahn H; Ryu J; Lee J; Mun SJ; Hong Y; Shin Y; Chung K; Son MJ
Cell J; 2022 Mar; 24(3):133-139. PubMed ID: 35451583
[TBL] [Abstract][Full Text] [Related]
20. Management of combined hepatocellular and cholangiocarcinoma.
Kassahun WT; Hauss J
Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
